Clinical Trial Update: Efficacy and Safety of ALT-801 in the Treatment of Obesity [Phase 2]

View source ↗

Summary

Phase 2 trial update on ALT-801 for obesity reporting efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity Overweight

Drugs mentioned

• ALT-801

Snippet

Sponsor: Altimmune, Inc. | Conditions: Obesity/Overweight | Phase 2 | Status: COMPLETED